Background: Minor dermatological procedures such as skin biopsy, electrocautery, cryotherapy, and excision of benign lesions frequently require local anesthesia to reduce procedural pain and improve patient comfort. Both topical anesthetics and injectable local anesthetics are commonly used, but their relative effectiveness, patient satisfaction, and complication profiles remain subjects of debate. Aim: To compare the efficacy, patient comfort, onset time, and complications associated with topical anesthesia and injectable local anesthesia in minor dermatological procedures. Methods: A prospective comparative study was conducted on 100 patients undergoing minor dermatological procedures at Pacific Institute of Medical Sciences, Udaipur, Rajasthan. Patients were randomly divided into two groups: Group A (topical anesthesia using eutectic mixture of lidocaine 2.5% and prilocaine 2.5%) and Group B (injectable anesthesia using 2% lidocaine infiltration). Pain perception was assessed using the Visual Analog Scale (VAS). Other parameters evaluated included onset time, duration of anesthesia, patient satisfaction, and complications. Statistical analysis was performed using Student’s t-test and Chi-square test. A p-value <0.05 was considered statistically significant. Results: Mean procedural pain score was significantly lower in the injectable anesthesia group (2.1 ± 0.9) compared with the topical anesthesia group (4.8 ± 1.2) (p < 0.001). However, pain during administration was significantly higher in the injectable group (4.2 ± 1.1 vs 0.9 ± 0.6, p < 0.001). Injectable anesthesia had a faster onset (2.5 ± 1.0 minutes vs 25.3 ± 4.5 minutes, p < 0.001). Minor complications such as erythema and edema were more frequent in the injection group but were not statistically significant. Conclusion: Injectable local anesthesia provides superior intra-procedural analgesia and faster onset compared with topical anesthetics, whereas topical anesthesia offers greater comfort during administration. Injectable anesthesia remains the preferred method for most minor dermatological procedures, while topical anesthesia may be useful for superficial procedures and needle-phobic patients.
In contrast, topical anesthetics, such as eutectic mixtures of lidocaine and prilocaine (EMLA), offer a non-invasive alternative that eliminates injection-related pain. These agents act by penetrating the skin and blocking sodium channels in nerve fibers, thereby preventing transmission of pain signals[3]. However, topical anesthetics often have a slower onset of action and may provide less profound anesthesia for deeper procedures.
Previous clinical studies have demonstrated varying results regarding the comparative efficacy of topical and injectable anesthetics. Injectable lidocaine has been shown to provide superior intra-procedural pain control compared with topical anesthetic creams in several studies[4-5]. However, topical anesthesia offers the advantage of painless application and improved patient acceptability.
Given the increasing number of outpatient dermatological procedures and the need to optimize patient comfort, it is important to evaluate the relative effectiveness of these anesthetic techniques[6].
The present study was conducted to compare topical anesthesia and injectable local anesthesia in terms of pain control, onset time, patient satisfaction, and complications during minor dermatological procedures[7].
This was a prospective comparative study conducted in the dermatology outpatient department of Pacific Institute of Medical Sciences, Udaipur, Rajasthan over a period of 06 months. A total of 100 patients undergoing minor dermatological procedures were included in the study. Inclusion Criteria • Patients aged 18–65 years • Patients undergoing minor dermatological procedures such as: o Skin biopsy o Wart removal o Electrocautery o Excision of benign lesions • Patients who provided informed consent Exclusion Criteria • Allergy to local anesthetics • Active infection at procedure site • Pregnancy or lactation • Patients with neurological disorders affecting pain perception • Patients on systemic analgesics or sedatives Sample Size A total of 100 patients were enrolled and randomly divided into two groups of 50 each. • Group A: Topical anesthesia (EMLA cream) • Group B: Injectable anesthesia (2% lidocaine infiltration) Procedure Group A: Topical Anesthesia • EMLA cream (lidocaine 2.5% + prilocaine 2.5%) was applied to the procedure site. • The area was covered with an occlusive dressing. • The cream was left in place for 30 minutes before the procedure. Group B: Injectable Anesthesia • 2% lidocaine solution was injected intradermally around the procedure site using a 26-gauge needle. • Procedure was performed once adequate anesthesia was achieved. Outcome Measures Primary Outcome • Pain during the procedure assessed using Visual Analog Scale (VAS) (0–10) Secondary Outcomes • Pain during administration of anesthesia • Onset time of anesthesia • Duration of anesthesia • Patient satisfaction • Complications (erythema, edema, infection) Statistical Analysis Data were analyzed using SPSS version 25. Statistical tests used: • Student’s t-test for continuous variables • Chi-square test for categorical variables A p-value < 0.05 was considered statistically significant.
Table 1: Demographic Characteristics of Patients
|
Variable |
Topical Group (n=50) |
Injectable Group (n=50) |
p-value |
|
Mean Age (years) |
36.2 ± 11.4 |
37.1 ± 10.8 |
0.68 |
|
Male |
28 (56%) |
30 (60%) |
0.68 |
|
Female |
22 (44%) |
20 (40%) |
0.68 |
|
Mean Procedure Duration (min) |
12.1 ± 3.4 |
11.8 ± 3.1 |
0.61 |
No statistically significant difference was observed between the two groups in terms of demographic characteristics.
Table 2: Comparison of Pain Scores
|
Parameter |
Topical Group |
Injectable Group |
p-value |
|
Pain during anesthesia administration (VAS) |
0.9 ± 0.6 |
4.2 ± 1.1 |
<0.001 |
|
Pain during procedure (VAS) |
4.8 ± 1.2 |
2.1 ± 0.9 |
<0.001 |
|
Overall pain score |
5.7 ± 1.3 |
3.8 ± 1.2 |
<0.001 |
Pain during anesthesia administration was significantly higher in the injectable group, whereas procedural pain was significantly lower.
Table 3: Onset and Duration of Anesthesia
|
Parameter |
Topical Group |
Injectable Group |
p-value |
|
Mean onset time (minutes) |
25.3 ± 4.5 |
2.5 ± 1.0 |
<0.001 |
|
Mean duration of anesthesia (minutes) |
60.4 ± 10.2 |
75.1 ± 12.3 |
<0.001 |
Injectable anesthesia demonstrated significantly faster onset and longer duration.
Table 4: Patient Satisfaction and Complications
|
Parameter |
Topical Group |
Injectable Group |
p-value |
|
High satisfaction |
32 (64%) |
40 (80%) |
0.04 |
|
Moderate satisfaction |
14 (28%) |
8 (16%) |
0.10 |
|
Low satisfaction |
4 (8%) |
2 (4%) |
0.40 |
|
Local erythema |
3 (6%) |
5 (10%) |
0.46 |
|
Local edema |
2 (4%) |
4 (8%) |
0.40 |
Patient satisfaction was significantly higher in the injectable group.
An essential part of dermatological procedures is effective pain control. In order to guarantee patient comfort, lower anxiety, and promote optimal operative outcomes, local anesthetic is crucial [8].
In this study, 100 patients had minor dermatological treatments, and topical anesthetic and injection local anesthesia were compared.
Pain Control
According to our research, injectable anesthesia outperformed topical anesthetic in terms of intra-procedural pain management [9]. The injectable group had a considerably lower mean VAS score during the procedure.
These results are in line with other research showing that lidocaine infiltration produces more potent analgesia than topical anesthetic creams.
Injectable anesthetics significantly reduced pain levels when compared to topical anesthetics (p < 0.001) in a prospective study of 100 individuals with keloids.
Because injectable anesthetic can reach deeper dermal nerve endings, it may have a better analgesic impact [10].
Pain during Administration
Although injectable anesthesia provides superior procedural analgesia, it is associated with pain during administration. In our study, patients reported significantly higher pain scores during injection compared with topical cream application[11].
Injection pain may result from tissue distension and the acidic pH of lidocaine solutions. Buffering lidocaine with sodium bicarbonate has been shown to reduce injection discomfort.
Onset Time
Topical anesthetics require approximately 20–30 minutes to achieve adequate anesthesia, whereas injectable lidocaine acts within a few minutes. Our results confirmed a significantly shorter onset time with injectable anesthesia[12].
Delayed onset is one of the main limitations of topical anesthetics and may prolong procedure preparation time.
Patient Satisfaction
Despite injection discomfort, overall patient satisfaction was higher in the injectable anesthesia group. This may be due to the more reliable pain control during the procedure.
Complications
In general, both anesthetic techniques were safe. Both groups experienced mild side effects as edema and erythema, but they were not statistically significant [13–14]. Although they are uncommon, topical anesthetics can occasionally result in methemoglobinemia or allergic responses.
Clinical Implications
The findings suggest that injectable anesthesia remains the preferred technique for most dermatological procedures requiring deeper tissue manipulation.
However, topical anesthesia may be particularly useful in:
Combining topical and injectable anesthesia may also improve patient comfort.
Limitations
The study had limitations:
Further multicenter randomized controlled trials are required to validate these findings.
The present study demonstrates that injectable local anesthesia provides significantly better intra-procedural analgesia and faster onset compared with topical anesthesia in minor dermatological procedures. However, topical anesthesia offers the advantage of painless application and may be beneficial for superficial procedures or patients with needle phobia. Injectable anesthesia remains the gold standard for most dermatological procedures requiring effective and reliable pain control.
An essential part of dermatological procedures is effective pain control. In order to guarantee patient comfort, lower anxiety, and promote optimal operative outcomes, local anesthetic is crucial [8].
In this study, 100 patients had minor dermatological treatments, and topical anesthetic and injection local anesthesia were compared.
Pain Control
According to our research, injectable anesthesia outperformed topical anesthetic in terms of intra-procedural pain management [9]. The injectable group had a considerably lower mean VAS score during the procedure.
These results are in line with other research showing that lidocaine infiltration produces more potent analgesia than topical anesthetic creams.
Injectable anesthetics significantly reduced pain levels when compared to topical anesthetics (p < 0.001) in a prospective study of 100 individuals with keloids.
Because injectable anesthetic can reach deeper dermal nerve endings, it may have a better analgesic impact [10].
Pain during Administration
Although injectable anesthesia provides superior procedural analgesia, it is associated with pain during administration. In our study, patients reported significantly higher pain scores during injection compared with topical cream application[11].
Injection pain may result from tissue distension and the acidic pH of lidocaine solutions. Buffering lidocaine with sodium bicarbonate has been shown to reduce injection discomfort.
Onset Time
Topical anesthetics require approximately 20–30 minutes to achieve adequate anesthesia, whereas injectable lidocaine acts within a few minutes. Our results confirmed a significantly shorter onset time with injectable anesthesia[12].
Delayed onset is one of the main limitations of topical anesthetics and may prolong procedure preparation time.
Patient Satisfaction
Despite injection discomfort, overall patient satisfaction was higher in the injectable anesthesia group. This may be due to the more reliable pain control during the procedure.
Complications
In general, both anesthetic techniques were safe. Both groups experienced mild side effects as edema and erythema, but they were not statistically significant [13–14]. Although they are uncommon, topical anesthetics can occasionally result in methemoglobinemia or allergic responses.
Clinical Implications
The findings suggest that injectable anesthesia remains the preferred technique for most dermatological procedures requiring deeper tissue manipulation.
However, topical anesthesia may be particularly useful in:
Combining topical and injectable anesthesia may also improve patient comfort.
Limitations
The study had limitations:
Further multicenter randomized controlled trials are required to validate these findings.
The present study demonstrates that injectable local anesthesia provides significantly better intra-procedural analgesia and faster onset compared with topical anesthesia in minor dermatological procedures. However, topical anesthesia offers the advantage of painless application and may be beneficial for superficial procedures or patients with needle phobia. Injectable anesthesia remains the gold standard for most dermatological procedures requiring effective and reliable pain control.